Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

Alx Oncology Holdings (ALXO) Debt Ratio (2019 - 2023)

Alx Oncology Holdings' Debt Ratio history spans 5 years, with the latest figure at 0.04 for Q3 2023.

  • For Q3 2023, Debt Ratio rose 162.79% year-over-year to 0.04; the TTM value through Sep 2023 reached 0.04, up 162.79%, while the annual FY2022 figure was 0.04, 351.92% up from the prior year.
  • Debt Ratio for Q3 2023 was 0.04 at Alx Oncology Holdings, up from 0.04 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.51 in Q4 2019 and bottomed at 0.01 in Q4 2021.
  • The 5-year median for Debt Ratio is 0.04 (2022), against an average of 0.08.
  • The largest annual shift saw Debt Ratio surged 351.92% in 2022 before it surged 162.79% in 2023.
  • A 5-year view of Debt Ratio shows it stood at 0.51 in 2019, then plummeted by 95.68% to 0.02 in 2020, then tumbled by 63.69% to 0.01 in 2021, then surged by 351.92% to 0.04 in 2022, then increased by 20.78% to 0.04 in 2023.
  • Per Business Quant, the three most recent readings for ALXO's Debt Ratio are 0.04 (Q3 2023), 0.04 (Q2 2023), and 0.04 (Q1 2023).